How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

    The content on this page is not current guidance and is only for the purposes of the consultation process.

    References

    1. Chughtai B, Elterman D, Shore N et al. (2021) The iTind temporarily implanted nitinol device for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a multicenter, randomized, controlled trial. Urology 153: 270−76

    2. Amparore D, Fiori C, Valerio M et al. (2021) 3-Year results following treatment with the second generation of the temporary implantable nitinol device in men with LUTS secondary to benign prostatic obstruction. Prostate Cancer and Prostatic Diseases; 2020 24, pages349–357

    3. De Nunzio C, Cantiello F, Fiori C et al. (2020) Urinary and sexual function after treatment with temporary implantable nitinol device (iTind) in men with LUTS: 6-month interim results of the MT-06-study. World Journal of Urology 39: 2037–42

    4. Porpiglia F, Fiori C, Bertolo R et al. (2018) 3-Year follow-up of temporary implantable nitinol device implantation for the treatment of benign prostatic obstruction. BJU international 122: 106–112